Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Improving ovarian cancer treatment decision using a novel risk predictive tool
Zhenyi Xu et al.
Aging-US (2022)
Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent
Minsun Jung et al.
MOLECULAR ONCOLOGY (2022)
A Novel Five-Gene Signature Related to Clinical Outcome and Immune Microenvironment in Breast Cancer
Yi Yang et al.
FRONTIERS IN GENETICS (2022)
A Pyroptosis-Related Gene Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer Based on Computational Biology Techniques
Zitao Wang et al.
FRONTIERS IN GENETICS (2022)
Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer
Mengping Jiang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma
Tianhao Hu et al.
FRONTIERS IN GENETICS (2022)
Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer
Hongfei Zhang et al.
FRONTIERS IN IMMUNOLOGY (2022)
A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer
Zhihao Zhang et al.
FRONTIERS IN GENETICS (2022)
Targeting tumor-associated macrophages as an antitumor strategy
Nan Cheng et al.
BIOCHEMICAL PHARMACOLOGY (2021)
NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion
Hongwei Lv et al.
CELL METABOLISM (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy
Patience Setordzi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Decision curve analysis to evaluate the clinical benefit of prediction models
Andrew J. Vickers et al.
SPINE JOURNAL (2021)
Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer
Anita K. Mehta et al.
FRONTIERS IN IMMUNOLOGY (2021)
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis
L. A. Emens et al.
ANNALS OF ONCOLOGY (2021)
The Elderly with Glucose-6-Phosphate Dehydrogenase Deficiency are More Susceptible to Cardiovascular Disease
Maria Pina Dore et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2021)
Landscape of Immune Microenvironment Under Immune Cell Infiltration Pattern in Breast Cancer
Qianhui Xu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Landscape and function of multiple mutations within individual oncogenes
Yuki Saito et al.
NATURE (2020)
Impact of metformin on immunological markers: Implication in its anti-tumor mechanism
George G. Chen et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer
Manuela Terranova-Barberio et al.
NATURE COMMUNICATIONS (2020)
Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer
Zhen Zhai et al.
JAMA NETWORK OPEN (2020)
Key steps for effective breast cancer prevention
Kara L. Britt et al.
NATURE REVIEWS CANCER (2020)
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Olga Martinez-Saez et al.
BREAST CANCER RESEARCH (2020)
An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
Silei Sui et al.
THERANOSTICS (2020)
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer
Song Wu et al.
NATURE COMMUNICATIONS (2019)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
Dvir Aran et al.
NATURE IMMUNOLOGY (2019)
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Andrew Butler et al.
NATURE BIOTECHNOLOGY (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Role of p53 Gene in Breast Cancer: Focus on Mutation Spectrum and Therapeutic Strategies
Raman Preet Kaur et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages
Shicheng Su et al.
CELL (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Breast cancer: The translation of big genomic data to cancer precision medicine
Siew-Kee Low et al.
CANCER SCIENCE (2018)
Risk factors and clinical characteristics of non-promyelocytic acute myeloid leukemia of intracerebral hemorrhage: A single center study in China
Qiaolei Zhang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Physiological and pathophysiological roles of NAMPT and NAD metabolism
Antje Garten et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
NAD+ in aging, metabolism, and neurodegeneration
Eric Verdin
SCIENCE (2015)
Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin
G. Dominguez-Gomez et al.
ONCOLOGY REPORTS (2015)
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
S. Loi et al.
ANNALS OF ONCOLOGY (2014)
Association between CD8+T-cell infiltration and breast cancer survival in 12 439 patients
H. R. Ali et al.
ANNALS OF ONCOLOGY (2014)
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
Paul Geeleher et al.
PLOS ONE (2014)
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
Paul Geeleher et al.
GENOME BIOLOGY (2014)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
NAMPT in Regulated NAD Biosynthesis and its Pivotal Role in Human Metabolism
E S. Burgos
CURRENT MEDICINAL CHEMISTRY (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
Ralph R. Weichselbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
GSEA-P:: A desktop application for Gene Set Enrichment Analysis
Aravind Subramanian et al.
BIOINFORMATICS (2007)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide
PJ Hoskin et al.
CANCER (2005)
Elevated serum arginase activity levels in patients with breast cancer
MF Polat et al.
SURGERY TODAY (2003)
ARCON: Experience in 215 patients with advanced head-and-neck cancer
JHAM Kaanders et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Share Paper
